RxSight, Inc.

RXST · Nasdaq · SIC 3851: Ophthalmic Goods
77
SEC Filings

Business Summary

RxSight, Inc. is a commercial-stage medical technology company focused on customized vision correction following cataract surgery. Its proprietary RxSight system is the first and only commercially available premium cataract technology enabling post-surgical vision customization. The system comprises the Light Adjustable Lens (LAL/LAL+), the Light Delivery Device (LDD), and accessories. The LAL is a photosensitive silicone-based intraocular lens adjusted via UV light patterns from the LDD to optimize patient visual outcomes after implantation.

Next Earnings

Q2 FY2026 — expected 2026-08-05

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionRXSTdiscussed_in_filing Healthcare & Bio
topic_mentionRXSTdiscussed_in_filing Healthcare & Bio
topic_mentionRXSTdiscussed_in_filing Healthcare & Bio
topic_mentionRXSTdiscussed_in_filing Healthcare & Bio

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-02-252025-12-310001193125-26-071775EDGAR98K words
2025-02-252024-12-310000950170-25-026681EDGAR—
2024-02-282023-12-310000950170-24-022073EDGAR—
2023-03-062022-12-310000950170-23-006237EDGAR—
2022-03-082021-12-310000950170-22-003135EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-052025-09-300001193125-25-266986EDGAR72K words
2025-08-072025-06-300000950170-25-105070EDGAR—
2025-05-072025-03-310000950170-25-065683EDGAR—
2024-11-072024-09-300000950170-24-123368EDGAR—
2024-08-052024-06-300000950170-24-090770EDGAR—
2024-05-062024-03-310000950170-24-053566EDGAR—
2023-11-092023-09-300000950170-23-062099EDGAR—
2023-08-072023-06-300000950170-23-039081EDGAR—
2023-05-092023-03-310000950170-23-019703EDGAR—
2022-11-072022-09-300000950170-22-022617EDGAR—
2022-08-082022-06-300000950170-22-015528EDGAR—
2022-05-052022-03-310000950170-22-007878EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-02-250001193125-26-071516EDGAR3K words
2026-01-120001193125-26-010478EDGAR—
2025-12-230001193125-25-331151EDGAR—
2025-12-220001193125-25-328951EDGAR—
2025-12-190001193125-25-326889EDGAR—
2025-11-050001193125-25-266938EDGAR—
2025-08-070000950170-25-105027EDGAR—
2025-08-040000950170-25-102065EDGAR—
2025-07-080000950170-25-094588EDGAR—
2025-06-040000950170-25-081636EDGAR—

77 total filings indexed. 50 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

BLCO — Bausch & Lomb Corp COO — COOPER COMPANIES, INC. LUCY — Innovative Eyewear Inc EYE — National Vision Holdings, Inc. STAA — STAAR SURGICAL CO WRBY — Warby Parker Inc.

Tags

premium-intraocular-lens-(iol)-market cataract-surgery-market premium-cataract-surgery-market ophthalmology-medical-device-market

Company Identity

CIK0001111485
TickerRXST
ExchangeNasdaq
SIC3851: Ophthalmic Goods
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 7714a35525d51efb8cfe23a9a42918d0c992657dc950435ec6d6cfa737074a5a
parent: 6193cad77aba4958be2a25859f56cd71188308cf457aa6d3589016b964552b67
content hash: 2a4438537936549e5d45d6c96c93102372d442ab336da083ae4e3d597c8bf1fd
signed: 2026-04-13T04:47:17.449Z
sources: 17 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf